Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-29T22:48:20.036Z Has data issue: false hasContentIssue false
  • English
  • Français

Adverse Events After Administration of Tetanus-Diphtheria-Acellular Pertussis Vaccine to Healthcare Workers

Published online by Cambridge University Press:  02 January 2015

Thomas J. Sandora ,
Elizabeth Pfoh  and
Grace M. Lee
Thomas J. Sandora*
Affiliation:
Division of Infectious Diseases, Children's Hospital Boston, Boston, Massachusetts Department of Laboratory Medicine, Children's Hospital Boston, Boston, Massachusetts
Elizabeth Pfoh
Affiliation:
Department of Ambulatory Care and Prevention, Harvard Medical School, and Harvard Pilgrim Health Care, Boston, Massachusetts
Grace M. Lee
Affiliation:
Division of Infectious Diseases, Children's Hospital Boston, Boston, Massachusetts Department of Laboratory Medicine, Children's Hospital Boston, Boston, Massachusetts Department of Ambulatory Care and Prevention, Harvard Medical School, and Harvard Pilgrim Health Care, Boston, Massachusetts
*
Division of Infectious Diseases, 333 Longwood Avenue, Children's Hospital Boston, Boston, MA 02115 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Healthcare workers who received the tetanus-diphtheria–acellular pertussis (Tdap) vaccine were surveyed about adverse events. Local adverse events were more common among women and among those who received the Tdap vaccine less than 5 years after they had received the tetanus-diphtheria vaccine. Systemic adverse events were more common among healthcare workers aged less than 30 years. These findings provide guidance for counseling of healthcare workers who receive Tdap vaccine.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 30 , Issue 4 , April 2009 , pp. 389 - 391
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Kretsinger, K, Broder, KR, Cortese, MM, et al.Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among healthcare personnel. MMWR Recomm Rep 2006;55(RR-17):1–37.Google Scholar
2.Halperin, SA, Sweet, L, Baxendale, D, et al.How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine? Pediatr Infect Dis J 2006;25:195–200.Google Scholar
3.Rennels, MB. Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines. Semin Pediatr Infect Dis 2003;14:196–198.CrossRefGoogle ScholarPubMed
4.Sekaran, NK, Edwards, KM. Extensive swelling reaction associated with diphtheria and tetanus toxoids and acellular pertussis vaccine. Pediatr Infect Dis J 2006;25:374–375.Google Scholar
5.Halperin, SA, Smith, B, Russell, M, et al.An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine 2000;18:1312–1319.Google Scholar
6.Pichichero, ME, Rennels, MB, Edwards, KM, et al.Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA 2005;293:3003–3011.Google Scholar
7.Turnbull, FM, Heath, TC, Jalaludin, BB, Burgess, MA, Ramalho, AC. A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults. Vaccine 2000;19:628–636.Google Scholar
8.Van der Wielen, M, Van Damme, P, Joossens, E, Francois, G, Meurice, F, Ramalho, A. A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults. Vaccine 2000;18:2075–2082.Google Scholar
9.Ward, JI, Cherry, JD, Chang, SJ, et al.Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005;353:1555–1563.CrossRefGoogle ScholarPubMed
10.Woo, EJ, Burwen, DR, Gatumu, SN, Ball, R. Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System. Clin Infect Dis 2003;37:351–358.Google Scholar